Limitations stated clinical research in humans is described as "limited" and unapproved status is named clearly
Although anemia is often a symptom, the condition is actually the end stage of an autoimmune inflammation of the stomach known as autoimmune atrophic gastritis, resulting in destruction of stomach cells by one's own antibodies (autoantibodies)
The total program is typically three to four months of active protocol time
Animal models suggest benefits for ulcer healing and inflammatory bowel disease
Additionally, there is some evidence that suggests it may play a role in the homocysteine metabolism, thereby offering potential cardiovascular benefits, although again, more research is necessary to validate this use
Researchers often choose this blend when studying growth hormone signaling pathways, peptide interactions, body composition mechanisms, and recovery-related biological processes